enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.770
-0.080 (-4.32%)
At close: Aug 20, 2026, 4:00 PM EDT
1.770
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:04 PM EDT
enGene Therapeutics Employees
As of October 31, 2025, enGene Therapeutics had 82 total employees, including 81 full-time and 1 part-time employees. The number of employees increased by 25 or 43.86% compared to the previous year.
Employees
82
Change (1Y)
25
Growth (1Y)
43.86%
Revenue / Employee
n/a
Profits / Employee
-$1,546,951
Market Cap
118.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Oct 31, 2025 | 82 | 25 | 43.86% | 81 | 1 |
| Oct 31, 2024 | 57 | 24 | 72.73% | 56 | 1 |
| Oct 31, 2023 | 33 | - | - | 31 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| Fractyl Health | 100 |
| Rani Therapeutics Holdings | 71 |
| Cue Biopharma | 29 |
| Oncolytics Biotech | 29 |
| Genelux | 26 |
| Black Diamond Therapeutics | 21 |
ENGN News
- 9 days ago - enGene Therapeutics Transcript: KOL event - Transcripts
- 9 days ago - enGene Therapeutics Slides: KOL event - Filings
- 16 days ago - enGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business Wire
- 5 weeks ago - enGene announces changes to board, appoints Heffernan as Chairman - TheFly
- 5 weeks ago - enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones - Business Wire
- 5 weeks ago - Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman - GlobeNewsWire
- 7 weeks ago - enGene Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - enGene downgraded to Underweight from Equal Weight at Morgan Stanley - TheFly